Literature DB >> 25155182

Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain.

Lena Lavie1.   

Abstract

Obstructive sleep apnea (OSA), characterized by intermittent hypoxia (IH), is linked with increased reactive oxygen species/reactive nitrogen species (ROS/RNS) and oxidative stress, which adversely affect the associated cardio-/cerebro-vascular disease in OSA. Yet, animal and a small number of human studies support activation of cardio-/cerebro-protective mechanisms as well. ROS/RNS are intricate and multifaceted molecules with multiple functions. At low-moderate concentrations ROS/RNS are considered "good", by regulating vital cellular functions. At higher levels, they are considered "bad" by promoting oxidative stress and damaging vital macromolecules through ischemia and reperfusion (I/R) injury. Subsequently, ROS/RNS can get "ugly" by eliciting sterile inflammation and a multitude of deadly pathologies. What makes ROS/RNS good, bad, or ugly? A dynamic interplay between a large number of factors determines the outcomes. These include the types of ROS/RNS produced, their quantity, duration, frequency, intracellular localization, micro-environmental antioxidants, as well as the genetic make-up and life style related variables. This review presents the currently available data on redox biology in physiological/pathophysiological conditions and in OSA/IH, in order to better understand the apparently contradictory findings on damage vs. repair. These findings are discussed within the context of the prevailing views on I/R associated ROS/RNS, and their potential implications to OSA.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Anti-oxidants; Coronary collaterals; Endothelial progenitor cells; Ischemia/reperfusion; Ischemic preconditioning; Obstructive sleep apnea; Oxidative stress; ROS/RNS; Stroke

Mesh:

Substances:

Year:  2014        PMID: 25155182     DOI: 10.1016/j.smrv.2014.07.003

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  166 in total

1.  Decreased Regional Cerebral Perfusion in Moderate-Severe Obstructive Sleep Apnoea during Wakefulness.

Authors:  Carrie R H Innes; Paul T Kelly; Michael Hlavac; Tracy R Melzer; Richard D Jones
Journal:  Sleep       Date:  2015-05-01       Impact factor: 5.849

2.  Serum Romo1 is significantly associated with disease severity in patients with obstructive sleep apnea syndrome.

Authors:  Liang Ye; Yingying Qian; Qian Li; Surong Fang; Zhenhua Yang; Yan Tan; Wei Gu
Journal:  Sleep Breath       Date:  2018-01-04       Impact factor: 2.816

Review 3.  [Chronic hypoxia and cardiovascular risk : Clinical significance of different forms of hypoxia].

Authors:  U Koehler; O Hildebrandt; J Krönig; W Grimm; J Otto; W Hildebrandt; R Kinscherf
Journal:  Herz       Date:  2017-05-04       Impact factor: 1.443

Review 4.  The role inflammatory response genes in obstructive sleep apnea syndrome: a review.

Authors:  Francisco Fábio Ferreira de Lima; Diego R Mazzotti; Sergio Tufik; Lia Bittencourt
Journal:  Sleep Breath       Date:  2015-07-23       Impact factor: 2.816

5.  Assessment of the relationship between polysomnography parameters and plasma malondialdehyde levels in patients with obstructive sleep apnea.

Authors:  Özden Savaş; Ahmet Emre Süslü; Incilay Lay; Serdar Özer
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-01       Impact factor: 2.503

6.  Association of continuous positive airway pressure with F2-isoprostanes in adults with obstructive sleep apnea: a meta-analysis.

Authors:  Zhi-Wei Huang; Wu Ouyang; Liang-Ji Zhang; Hao Li; Yu-Ming Ye; Xue-Jun Lin; Qiao-Zhen Xu; Li Lin; Li-Da Chen
Journal:  Sleep Breath       Date:  2019-02-07       Impact factor: 2.816

Review 7.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

8.  Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans.

Authors:  Miklos Z Molnar; Istvan Mucsi; Marta Novak; Zoltan Szabo; Amado X Freire; Kim M Huch; Onyebuchi A Arah; Jennie Z Ma; Jun L Lu; John J Sim; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Thorax       Date:  2015-06-02       Impact factor: 9.139

9.  Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea.

Authors:  Barbara J Morgan; Mihaela Teodorescu; David F Pegelow; Emily R Jackson; Devin L Schneider; David T Plante; James P Gapinski; Scott J Hetzel; John M Dopp
Journal:  Exp Physiol       Date:  2018-06-08       Impact factor: 2.969

10.  Cerebral and Muscle Oxygenation During Intermittent Hypoxia Exposure in Healthy Humans.

Authors:  Thomas Rupp; Arthur Peyrard; Renaud Tamisier; Jean-Louis Pepin; Samuel Verges
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.